RHYTHM PHARMACEUTICALS INC (RYTM) Stock Balance Sheet
NASDAQ:RYTM - US76243J1051 - Common Stock
103.15 USD
-1.08 (-1.04%)
103.15 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 135.59M | 89.14M | 60.08M | 127.70M | 59.20M | |||
| Marketable Securities | 155.44M | 231.43M | 215.76M | 205.60M | 235.60M | |||
| Receivables | 26.12M | 18.51M | 14.87M | 6.20M | 1.00M | |||
| Inventories | 18.87M | 18.74M | 8.62M | 2.90M | N/A | |||
| Other Current Assets | 24.66M | 16.38M | 8.93M | 11.80M | 12.50M | |||
| Total Current Assets | 360.68M | 374.20M | 308.27M | 354.20M | 308.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.56M | 4.11M | 2.12M | 3.40M | 4.30M | |||
| Intangibles | 5.75M | 6.17M | 7.03M | 7.90M | 4.70M | |||
| Other Non-Current Assets | 2.75M | 7.79M | 15.33M | 17.00M | 12.10M | |||
| Total Non-Current Assets | 12.05M | 18.07M | 24.48M | 28.30M | 21.10M | |||
| TOTAL ASSETS | 372.73M | 392.27M | 332.75M | 382.50M | 329.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 3.78M | 1.54M | N/A | N/A | N/A | |||
| Accrued Expenses | 47.17M | 46.81M | 39.56M | 33.60M | 30.70M | |||
| Accounts Payable | 15.98M | 12.33M | 4.88M | 4.80M | 5.70M | |||
| Other Current Liabilities | 62.52M | 54.84M | 10.76M | 1.40M | 7.00M | |||
| Total Current Liabilities | 129.46M | 115.52M | 55.20M | 39.80M | 43.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 106.01M | 108.27M | 106.14M | 75.80M | 0.00 | |||
| Other Non-Current Liabilities | 3.68M | 3.94M | 1.64M | 2.60M | 1.90M | |||
| Total Non-Current Liabilities | 109.69M | 112.21M | 107.78M | 78.40M | 2.00M | |||
| TOTAL LIABILITIES | 239.15M | 227.72M | 162.99M | 118.20M | 45.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.25B | -1.16B | -894.74M | -710.10M | -528.90M | |||
| Additional Paid In Capital | 1.24B | 1.18B | 1.06B | 974.40M | 813.00M | |||
| Common Shares | 145.56M | 142.88M | 59.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -2.25M | -39.00K | 134.00K | -100.00K | 0.00 | |||
| Shares Outstanding | 63.91M | 62.39M | 59.43M | 56.60M | 50.30M | |||
| Tangible Book Value per Share | -0.28 | 0.25 | 2.74 | 4.53 | 5.56 | |||
| Total Shareholders' Equity | 133.58M | 164.55M | 169.76M | 264.30M | 284.20M | |||
| TOTAL LIABILITIES AND EQUITY | 372.73M | 392.27M | 332.75M | 382.50M | 329.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.79 | 0.66 | 0.63 | 0.29 | N/A | |||
| Current Ratio | 2.79 | 3.24 | 5.58 | 8.90 | 7.11 | |||
| Return On Assets (ROA) | -50.55% | -67.45% | -55.50% | -47.35% | -21.13% | |||
| Return On Equity (ROE) | -141.04% | -160.79% | -108.79% | -68.53% | -24.49% | |||
All data in USD , ROIC based on taxRate of 0.21